Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Anushka Mukherjee

REVEALED: What to expect from kenvues q2 2026 earnings report | Rare Historical Photos

New Jersey-based Kenvue Inc. (KVUE) is the world's largest pure-play consumer health company by revenue, backed by more than a century of trusted innovation. Home to household names such as Aveeno, BAND-AID, Johnson's, Listerine, Neutrogena, and Tylenol, the company combines science-backed products with strong healthcare professional endorsements. By delivering everyday essentials that millions rely on, Kenvue has earned a lasting place in consumers' homes and in the global consumer health market.

With a market capitalization of roughly $36.5 billion, Kenvue is gearing up to report its fiscal 2026 second-quarter results soon. Wall Street expects the consumer health giant to deliver earnings of $0.32 per share, marking a 10.3% year-over-year increase. Investors have reason for optimism, as Kenvue has surpassed analysts' earnings estimates in each of the past four quarters.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.